Immuno-Biological Laboratories Co Ltd
TSE:4570
Immuno-Biological Laboratories Co Ltd
Gross Profit
Immuno-Biological Laboratories Co Ltd
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Immuno-Biological Laboratories Co Ltd
TSE:4570
|
Gross Profit
¥489.1m
|
CAGR 3-Years
25%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
2%
|
|
CMIC Holdings Co Ltd
TSE:2309
|
Gross Profit
¥20.8B
|
CAGR 3-Years
13%
|
CAGR 5-Years
7%
|
CAGR 10-Years
6%
|
|
S
|
Shin Nippon Biomedical Laboratories Ltd
TSE:2395
|
Gross Profit
¥14.3B
|
CAGR 3-Years
24%
|
CAGR 5-Years
18%
|
CAGR 10-Years
10%
|
Medinet Co Ltd
TSE:2370
|
Gross Profit
¥108.6m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-20%
|
|
CellSource Co Ltd
TSE:4880
|
Gross Profit
¥3.2B
|
CAGR 3-Years
36%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
Linical Co Ltd
TSE:2183
|
Gross Profit
¥4.1B
|
CAGR 3-Years
15%
|
CAGR 5-Years
1%
|
CAGR 10-Years
11%
|
See Also
What is Immuno-Biological Laboratories Co Ltd's Gross Profit?
Gross Profit
489.1m
JPY
Based on the financial report for Dec 31, 2023, Immuno-Biological Laboratories Co Ltd's Gross Profit amounts to 489.1m JPY.
What is Immuno-Biological Laboratories Co Ltd's Gross Profit growth rate?
Gross Profit CAGR 10Y
2%
Over the last year, the Gross Profit growth was -1%. The average annual Gross Profit growth rates for Immuno-Biological Laboratories Co Ltd have been 25% over the past three years , -1% over the past five years , and 2% over the past ten years .